Rebecca Creskoff
Nora
Search results
2 days ago · Clearmind is a clinical-stage psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved ...
Jan 1, 2024. In Theaters At Home TV Shows. Advertise With Us. When a grieving mother uses her virtual reality simulation to crash the weekend getaway of her former friends, what begins as an...
- (5)
- Comedy, Mystery & Thriller, Action, Drama
Nov 17, 2022 · November 17, 2022. VANCOUVER, Nov. 17, 2022 -- Clearmind Medicine Inc. (Nasdaq and CSE: CMND ), (FSE: CWY) (“Clearmind” or the “Company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, today announced the closing of its underwritten public ...
Clearmind develops novel psychedelic medicines to solve widespread—yet under-served—health problems. With a strong medical management and IP-protected treatments, we can better the lives of millions.
BenzingaWhy Clearmind Medicine Stock Is Moving Higher - Clearmind Medicine (NASDAQ:CMND)
Clearmind Medicine shares are up Tuesday after the company announced it signed an exclusive patent l...
2 days ago
- The Shelby County Reporter
Small Business - Shelby County Reporter | Shelby County Reporter
Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery an...
2 days ago
Feb 23, 2024 · Vancouver, Canada, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the "company"), a biotech company focused on discovery and...
Meet the hearts and minds that collaborate in bringing REAL Connection to the world - Clearmind style!
2 days ago · Vancouver, Canada, May 07, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announces the signing of an exclusive patent licensing agreement with Yissum Research Development ...
